A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT06669247 · RECRUITING
Trial details
- NCT number
- NCT06669247
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-11
- Primary completion
- 2033-11-11
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.